Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.